LGL Group (NYSEAMERICAN:LGL) Share Price Crosses Above 200-Day Moving Average – Time to Sell?

LGL Group, Inc. (The) (NYSEAMERICAN:LGL) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $6.87 and traded as high as $6.93. LGL Group shares last traded at $6.90, with a volume of 4,138 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of LGL Group to a “hold” rating in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, LGL Group presently has an average rating of “Hold”.

LGL Group Stock Down 0.1%

The firm has a fifty day moving average price of $6.96 and a 200-day moving average price of $6.88. The firm has a market cap of $45.13 million, a price-to-earnings ratio of 690.69 and a beta of 0.32.

Institutional Trading of LGL Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Osaic Holdings Inc. increased its stake in shares of LGL Group by 15.5% during the 2nd quarter. Osaic Holdings Inc. now owns 20,250 shares of the industrial products company’s stock valued at $154,000 after acquiring an additional 2,710 shares during the last quarter. Renaissance Technologies LLC grew its holdings in LGL Group by 3.6% in the first quarter. Renaissance Technologies LLC now owns 166,594 shares of the industrial products company’s stock valued at $1,158,000 after purchasing an additional 5,773 shares during the period. Citadel Advisors LLC purchased a new stake in LGL Group in the third quarter valued at approximately $90,000. Finally, Gamco Investors INC. ET AL increased its position in LGL Group by 2.8% during the first quarter. Gamco Investors INC. ET AL now owns 670,781 shares of the industrial products company’s stock worth $4,662,000 after purchasing an additional 18,305 shares during the last quarter. Hedge funds and other institutional investors own 30.28% of the company’s stock.

LGL Group Company Profile

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.